STOCK TITAN

IQVIA Holdings Inc. Form 4 Filings

IQV NYSE

Every Form 4 that IQVIA Holdings Inc. (IQV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow IQV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IQV filings page.

Rhea-AI Summary

IQVIA Holdings (IQV): Form 4 shows director equity activity. Director Colleen A. Goggins acquired 181 deferred share units on 11/05/2025 at $210.12 each. Following the transaction, she holds 4,702 deferred share units directly.

Each deferred share converts 1-for-1 into IQVIA common stock upon settlement. Under the company’s Non-Employee Director Deferral Plan, settlement occurs when the director ceases service, upon a change in control, or upon death. The deferred shares have no expiration date.

Rhea-AI Summary

IQVIA Holdings Inc. (IQV) reported an insider equity change as a director acquired 193 deferred shares on 11/05/2025 at a recorded derivative security price of $210.12, according to a Form 4 filing.

Each deferred share is convertible into one share of common stock upon settlement, which occurs when the director ceases to serve, upon a change in control of the company, or upon death, with no expiry date. Following this transaction, the director beneficially owned 4,063 deferred share units directly.

Rhea-AI Summary

IQVIA Holdings (IQV): Director Form 4 update. Director John G. Danhakl reported acquiring 158 deferred shares on 11/05/2025 at a price of $210.12 per unit. Following this transaction, he beneficially owned 2,772 derivative securities.

These deferred shares convert into one share of IQVIA common stock upon settlement. Under the company’s Non-Employee Director Deferral Plan, settlement occurs when the director leaves the board, upon a change in control of the company, or upon the director’s death. The deferred shares have no expiration date. Ownership is reported as direct.

Rhea-AI Summary

IQVIA Holdings Inc. (IQV): Executive Vice President and General Counsel Eric Sherbet reported insider transactions on 10/29/2025. He exercised stock appreciation rights at $131.82 to acquire 10,000 shares, then sold 4,000 shares at a weighted average price of $219.70 (ranging from $219.66 to $219.92) and 6,000 shares at $219.72. Following these trades, he directly owns 21,108 shares. The SARs related to 10,000 underlying shares (exercisable since 02/13/2022, expiring 02/13/2029), with 8,436 derivative securities remaining beneficially owned.

Rhea-AI Summary

IQVIA (IQV) insider transaction: On 10/29/2025, Chairman, Chief Executive Officer & President Ari Bousbib exercised stock appreciation rights for 77,592 shares at an exercise price of $59.90, then sold shares in multiple open‑market transactions. The reported weighted average sale prices ranged from $216.70 to $222.27 across the disclosed trade batches.

Following these transactions, Bousbib beneficially owned 807,163 shares directly. He also reported 543,302 shares held indirectly by a trust.